cd38 inhibitor and 5-amino-1mq synergy nad+ as theranostic target in oncology | Journal of Translational Medicine SLC25A51 decouples the mitochondrial NAD+/NADH

SLC25A51 decouples the mitochondrial NAD+ NADH ratio to control proliferation of AML cells: Cell Metabolism CD38 is a key mediator of NAD+ depletion in the brain of ZIKV infected mice: iScience Evolving roles of CD38 metabolism in solid tumour microenvironment British Journal of Cancer New Insights on Muscle Strength: The Role of Inhibiting an Enzyme that Hinders NAD+ Synthesis Flavonoid Apigenin Is an Inhibitor of the NAD+ase CD38: Implications for Cellular NAD+ Metabolism, Protein Acetylation, and Treatment of Metabolic Syndrome PMC Inhibition of CD38 enzymatic activity enhances CAR T cell immune therapeutic efficacy by repressing glycolytic metabolism ScienceDirect

SKU: 76069221773 · From ldesquadrias.com.br